Clover Biopharmaceuticals receives approval to initiate clinical trials of SCB-808 in China Dec. 28, 2017
Izana Bioscience launches, obtains rights to Takeda's namilumab for ankylosing spondylitis Dec. 18, 2017
pSivida announces phase I data on sustained-release implant for osteoarthritis of the knee Dec. 15, 2017
RSS